NeuroSense Therapeutics Ltd. financial statements
NeuroSense Therapeutics Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 11.13M | 20-F |
| Cash and equivalents | USD 166K | 20-F |
| Total debt | USD 170K | EODHD |
NeuroSense Therapeutics Ltd. financials on 6ix · NeuroSense Therapeutics Ltd. on 6ix